Lumit® Active IL-18 (Human) Immunoassay

new-kit-box

No-Wash Immunoassay for Active IL-18 Detection

  • Specific detection of mature/active IL-18
  • Fast add-and-read protocol
  • Scalable and flexible assay format to meet your needs
  • Available under our Early Access program
  • Scalable to 96- or 384- well plates, protocols included
  • Pack sizes show assay number for 96-well plates

Please Enquire
This product is discontinued
This product is available under our Early Access program - Learn More
This product is available under our Catalog (FT) program - Learn More
Lumit® Active IL-18 (Human) Immunoassay

Quantify Inflammasome Activation Without Tedious Wash Steps

The Lumit® Active IL-18 Immunoassay quantitatively measures active IL-18 in cell culture samples using a simple, no-wash protocol. Just add labeled binding protein with treatment, add labeled antibody, add detection reagent and read luminescent signal using a standard plate-reading luminometer. The entire protocol is completed in less than 70 minutes! The assay can be used directly on cells in culture or culture medium samples transferred to a separate assay plate.

Note: The total number of assays per kit will vary based on final well volume.

For standard well volumes:

  • 100 assay kits: applicable for 100 assays in 96-well plates or 400 assays in 384-well plates.
  • 500 assay kits: applicable for 500 assays in 96-well plates or 2,000 assays in 384-well plates.
  • 1,000 assay kits: applicable for 1,000 assays in 96-well plates or 4,000 assays in 384-well plates.

How the Lumit® IL-18 Immunoassay Works

The Lumit® IL-18 Immunoassay uses one primary antibody to IL-18, selected for its specificity and sensitivity, and labeled with the LgBiT subunit of NanoBiT® luciferase in combination with the IL-18 Binding Protein, labeled with the SmBiT subunit of NanoBiT® Luciferase. In the presence of cleaved, mature IL-18, the NanoBiT® subunits are brought together to form an active luciferase enzyme. Addition of the optimized luciferase substrate generates a bright luminescent signal proportional to active IL-18 levels. The assay is specific to active IL-18 and does not detect pro-IL-18 or inactive IL-18 bound by endogenous IL-18 binding protein.

Schematic of Lumit™ IL-18 Immunoassay concept showing anti-IL-18-LgBiT and SmBiT-IL-18 binding protein binding to IL-18 and forming NanoBiT® Luciferase.

Simple One-Plate Protocol Requires No Wash Steps

assay protocol part 1
assay protocol part 2

Broad Linear Range of Lumit® IL-18 Detection

The picomolar to nanomolar linear detection range of Lumit® IL-18 Immunoassay covers expected concentrations for most cell models.

Graph showing standard curve for Lumit™ IL-18 (Human) Immunoassay.

Specification

Lumit® IL-18 Immunoassay

Limit of Detection

≤10pg (3 SD above background)

Dynamic Range

11pg–20ng

Assay Time

70 minutes

Sample Type

Cell culture supernatants

SD=Standard Deviation

Featured Webinar

Using Lumit® Technology to Address Inflammasome-Mediated Cytokine Release

In this webinar, Promega Sr. Research Scientist, Dr. Martha O’Brien, describes developing tools to measure inflammasome activation, including the Lumit® Active IL-18 Immunoassay and Lumit® IL-1β Immunoassay. Dr. O’Brien shows how Lumit® Assays can be multiplexed with other inflammasome assays to identify and rank the potency of inflammasome inhibitors.

View On-Demand Webinar

Want to see all the data?

Download the Scientific Poster

Detect IL-18 Release Following Inflammasome Activation

Bar graph showing active IL-18 detection in cells treated with Nigericin and LPS + Nigericin.

The Lumit® Active IL-18 (Human) Immunoassay was used to quantitate secretion of active IL-18 from THP-1 cells following treatment. Active IL-18 is found in cell culture media samples following treatment with either nigericin or nigericin + LPS but not in untreated cells or cells treated with LPS alone. The amount of active IL-18 secreted was calculated using the standard curve. Data shown is an average of 3 replicates; error bars represent standard deviation.

Looking for additional tools to monitor inflammasome activation? Visit our Inflammasome Activation Page.

Patents and Disclaimers

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 10,648,971 and other patents and patents pending.

Resources

Articles

Similar Products

Lumit® IL-1β Human/Mouse Immunoassay

Quantifies inflammasome activation by measuring released IL-1β using a simple, no-wash protocol.

W6010, W6011, W6012, W7010, W7011, W7012, W116A-C, W119A-C

Caspase-Glo® 1 Inflammasome Assay

A homogeneous, bioluminescent method to selectively measure the activity of caspase-1, an essential component of the inflammasome.

G9951, G9952, G9953

RealTime-Glo™ Extracellular ATP Assay

Bioluminescent assay designed for continuous, kinetic monitoring of ATP released from dying, stressed or activated cells.

GA5010, GA5011, GA5012

LDH-Glo™ Cytotoxicity Assay

Bioluminescence-based LDH assay for sensitive detection of cytotoxicity in samples low in cell number, including 3D microtissues.

J2380, J2381

Let's find the product that meets your needs.

Talk to a Scientist

scientist-uk-angus

Angus

UK
Choose your country

Americas

Brazil
/
Canada
/
United States
/

Pacific Asia

Australia
China
India
Japan
/
Republic of Korea
/
Singapore

Europe

Austria
/
Belgium
Denmark
Estonia
Finland
France
/
Germany
/
Iceland
Ireland
Italy
/
Luxembourg
Netherlands
Norway
Poland
/
Portugal
Spain
/
Sweden
Switzerland
United Kingdom

Manage Cookies

Necessary Cookies

We use these cookies to ensure our site functions securely and properly; they are necessary for our services to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as logging in, using a shopping cart or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of our services will not work without them. Like the other cookies we use, strictly necessary cookies may be either first-party cookies or third - party cookies.

Preference Cookies

We use these cookies to remember your settings and preferences. For example, we may use these cookies to remember your language preferences.

Performance/Statistics Cookies

We use these cookies to collect information about how you interact with our services and to help us measure and improve them. For example, we may use these cookies to determine if you have interacted with a certain page.

Marketing Cookies

We and our advertising partners use these cookies to deliver advertisements, to make them more relevant and meaningful to you, and to track the efficiency of our advertising campaigns, both on our services and on other websites and social media.

Your Privacy Choices

Our website supports your privacy choices by allowing users in select regions to opt out of specific types of sharing/sales/use of cookies and technologies for Targeted Advertising. Visit our Privacy Policy and Cookie Policy pages to learn more about these topics.

Targeted Advertising

Deselect this checkbox to disable cookies related to targeted advertising in your Promega experience. These advertising cookies will no longer be set for this browser and device.

Note: These settings are based on necessary cookies that are placed on your device, and if those cookies are cleared or you access the website from another browser or device, advertising cookies might be reset by default in the future, from which you can opt-out.